APA (7th ed.) Citation

Wittkowski H, Kuemmerle-Deschner JB, Gramlich K, Tzaribachev N, Felix SD, Jung T, . . . Foell D. (2008). The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885). BMC.

Chicago Style (17th ed.) Citation

Wittkowski H, Kuemmerle-Deschner JB, Gramlich K, Tzaribachev N, Felix SD, Jung T, Roth J, Rordorf C, and Foell D. The Phagocyte Specific Protein S100A12 as a Novel Biomarker in Muckle-Wells-Syndrome Before and During Therapy with Anakinra and Canakinumab (ACZ885). BMC, 2008.

MLA (9th ed.) Citation

Wittkowski H, et al. The Phagocyte Specific Protein S100A12 as a Novel Biomarker in Muckle-Wells-Syndrome Before and During Therapy with Anakinra and Canakinumab (ACZ885). BMC, 2008.